Expert NetworkExpert InterviewGILD

Slingshot members are talking to an expert! The topic is:

Looking at the SOC for triple negative breast cancer and the data presented at ESMO2025 from AstraZeneca (Datroway) and Gilead (Trodelvy)

Executed on:Jan 7, 2026 6:15 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Advanced Care Oncology And Hematology Associates
  • Medical Oncologist & Partner at ACOHA (private practice in New Jersey); fellowship trained at New York Presbyterian-Columbia University Medical Center.
  • Manages 400 patients with solid tumors and 25 patients with gastroesophageal junction cancer.
  • Lectures widely on Gastrointestinal, Genitourinary and breast malignancies.

Interview Goal

This conversation will focus on the treatment landscape and potential use of Datroway and Trodelvy in patients with triple negative breast cancer. 

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.